Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Jason Gallagher Discusses FDA’s Decision to Revoke Emergency Use Authorization for Last Remaining Monoclonal Antibody Treatment for COVID-19

View All News

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, spoke with Verywell Health about the U.S. Food and Drug Administration (FDA)’s decision to revoke emergency use authorization for the last remaining monoclonal antibody treatment for COVID-19.